Development and Validation of RP-HPLC Method for Determation of Acyclovir in Ointment
Ajay Bedadurge, Kadare Mahesh, Vinod Matole*, Parikshit Shirure, Sainath Suryawanshi, Ghodake Kajal
Shivai Charitable Trusts College of Pharmacy, Koregaonwadi, Omerga.
*Corresponding Author E-mail: matole7414@gmail.com
ABSTRACT:
The analytical method was developed and validated for determination of acyclovir in ointment by High performance liquid chromatography. The separation was carried out on Luna C18 column (250 × 4.6mm × 5µ). The mobile phase consists of water: acetonitrile in the ratio 88:12 at flow rate 0.8ml/min with diode array detector wavelength at 254nm.The column temperature was adjusted at 30ºC±40ºC with injection volume 20µl.The retention time of acyclovir was 4.747min. The linearity of the calibration curve was linear over the concentration range 80-120µg/ml (r2=0.9996). The validation was carried out as per ICH guidelines. The development method was easy, rapid, linear, precise, accurate and consistent.
KEYWORDS: Acyclovir, Method development, HPLC, Validation, 254nm, Diode array detector.
1. INTRODUCTION:
Acyclovir [2-amino-9(2-hydroxyethoxy) methyl)-1, 9 dihydro-6Hpurine-6-one] is an antiviral agent. Acyclovir is a white crystalline powder. Acyclovir is sparingly soluble in water freely soluble in dimethyl sulfoxide (DMSO) and very slightly soluble in alcohol.1 It is used in the of treatment of virus infection, chickenpox and shingles. It is a synthetic moiety of deoxyguanosine in which the carbohydrate moiety is acyclic.1Acyclovir is used to control the symptoms of infection involving herpes simplex virus (HSV) type-1 and type-2 which causes herpes simplex, varicella zoster virus (VZV) causes shingles and chickenpox.
Acyclovir also known as acycloguanosine, antiviral drug which is used to control the symptoms of infection involving herpes simplex virus (HSV) type-1 and type-2 which causes herpes simplex, or varicella zoster virus (VZV) causes shingles and chickenpox. Other uses include prevention of cytomegalovirus infections following transplant and infection due to Epstein-Barr virus.2
Figure1: Structure of Acyclovir
The Mode of action of acyclovir consists of three mechanisms:
The first mechanism involve acyclovir is converted by viral thymidine kinase to acyclovir monophosphate. This phosphorylation reaction occurs faster within cells infected by herpes virus than in normal cells, which is then converted di and tri phosphates by a normal cellular enzyme called guano sine monophosphate kinase.
In the second mechanism acyclovir triphosphate prevents synthesis of viral DNA polymerase with a lower median inhibition concentration. Acyclovir triphosphate lacks the 3-hydroxyl group of a cyclic sugar; so that acyclovir triphosphate is integrated into the viral DNA synthesis it completes more elongation of DNA chain.
The third mechanism depends on preferential uptake of acyclovir by herpes infected cells as compared to uninfected cells, resulting in a higher concentration of acyclovir triphosphate and leading to a high therapeutic index between herpes infected cell compared to normal cells. Acyclovir is active against certain herpes virus infections these viruses induce virus specific thymidine kinase and DNA polymerase, which are inhibited by acyclovir. So, acyclovir significantly decreases DNA synthesis in virus infected cells without significantly disturbing the active replication of uninfected cells.
Spectrophotometric methods, HPLC method is reported for estimation of acyclovir. However, HPLC method for estimation of acyclovir in ointment is not reported. Hence, the aim of this study is to develop HPLC method for the determination of acyclovir in Ointment.
2. MATERIAL AND METHOD:
2.1 Material:
Acyclovir was taken as gift sample from Adhar Life Sciences. The solvents such as HPLC grade water and acetonitrile (Merk) Mumbai, India. 0.45µm Millipore syringe filters (Ultipor® N 66® Nylon 6, 6 Membrane) were from Pall Life Sciences, India.
2.2 Instruments:
HPLC system (Agilent1260 infinity II autosampler). In addition, an electronic balance (ACZET), a sonicator (LABMAN), a vortex machine (REMI CM-1101 PLUS)
2.3 Chromatographic condition:
The analysis was carried out on HPLC system (Agilent1260 infinity II) equipped with auto sampler and diode array detector (DAD) The separation was achieved on Luna C18 column (250×4.6mm× 5µ) using water and acetonitrile as a mobile phase in the ratio of 88:12 with injection volume 20µl and flow rate of 0.8 ml/min. with column temperature 30º±0.8ºc. And the detector wavelength set at 254nm.
2.4 Preparation of standard stock solution:
10mg of acyclovir API was weighed and transferred in 10ml of volumetric flask dissolved in water and acetonitrile (88:12) as a diluent and the volume was made up to the mark with the same diluents sonicate for 5 min and vortex.
2.5 Preparation of ointment stock solution:
0.2gm of acyclovir ointment was weighed and transferred in 10ml of volumetric flask dissolved in water and acetonitrile (88:12) as a diluent. Vortex, sonicate for 5 min. and then again vortex and heat it at 60ºC in water bath for 10-15 min.
Method Development:
The main aim of this study was to determination of acyclovir in ointment. HPLC method was developed and optimized in terms of the mobile phase selection, composition, wavelength, choice of stationary phase of column, flow rate and column temperature. Acyclovir showed the absorbance maxima 254nm. Hence detection at 254nm was selected for the method development.
Figure2: Chromatogram of Acyclovir
Figure3: Linearity overlay of Acyclovir
3.VALIDATION PARAMETERS:
I. Specificity:
The analytical parameter specificity is the ability to find the analyte in presence of other components such as impurities, degradants, matrix etc. From the ointment stock solution 1 ml solution was spiked out and volume was made up to the mark using water and acetonitrile (88:12) as a diluent the solution was vortexed for 5 minutes. The solution was filtered using 0.45µm Millipore syringe filter. This solution was assayed at 254 nm using mobile phase water: acetonitrile (88:12)
II. Linearity and Range:
Linearity of an analytical procedure is its ability to detect test results which is directly proportional to the concentration (amount) of analyte present in the sample.
Range of an analytical procedure is the differential interval between the upper and lower concentration (amount) of analyte present in the sample.
Linearity was checked by preparing standard solutions at five concentrations i.e. 80, 90, 100, 110 and 120µg/ml using standard stock solution. These concentrations were injected into the HPLC system to get the chromatogram. The linearity range was found to be 80-120µg/ml respectively.
III. Precision:
Precision of an analytical parameter is near to the test results to that of the true value obtained from multiple sampling of a homogenous sample under the prescribed experimental conditions. Precision was evaluated for reproducibility, inter-day and intra-day analysis.
1ml of sample was spiked out from the standard stock solution into a 10ml volumetric flask; volume was made upto mark using diluent (water: acetonitrile). This solution was vortexed for 5 minutes filtered using 0.45µ Millipore syringe filter and filled into HPLC vials.
IV. Accuracy:
The accuracy of an analytical parameter is the closeness of the test results to true value. Accuracy of the proposed method was done by standard addition method or recovery study by spiking out the standard stock solution.
V. LOD and LOQ:
The limit of detection (LOD) gives information about the lowest amount of analyte present in the sample which can be easily detected but not necessarily quantified.
Limit of quantitation (LOQ) of an analytical parameter gives information about the lowest amount of analyte present in the sample which can be easily detected, and quantified with suitable precision and accuracy.
Limit of detection and Limit of Quantitation were determined using the following equations;
LOD= 3.3*σ/S
LOQ= 10*σ/S
Where, σ = Standard deviation, and S= slope of the regression coefficient.
4. RESULTS AND DISCUSSION:
The developed and optimized method in HPLC was considered for method validation. The spectral investigation by HPLC of acyclovir standard solution showed peak at 4.747min. The optimization was carried out using water: acetonitrile as mobile phase. In the ratio of 88:12 with flow rate 0.8ml/min. The linearity of the calibration curve was linear over the concentration range 80-120µg/ml (r2=0.9988). The precision method was showed by reproducibility studies. The % RSD value was less than 2% it showed that method was precise. The optimized method of accuracy was determined by percentage recovery method, the percentage recovery was found to be 100.13%, 100%, 99.80% for 80%, 100%, 120% respectively. The detection limit and quantification limit were found to be 3.1µg/ml and 9.38 µg/ml. The results are discussed below.
Table 1: Results of Specificity
|
Sample |
Weight |
Area |
Assay |
|
WS |
5.1 |
3231466 |
- |
|
DP |
0.87 |
2257396 |
99.72 |
Table 2: Results of Linearity
|
% CONC. |
Conc. µg/ml |
Area |
|
80 |
80 |
2495622 |
|
90 |
90 |
2782514 |
|
100 |
100 |
3115408 |
|
110 |
110 |
3426306 |
|
120 |
120 |
3730868 |
Figure 4: Calibration curve of Acyclovir
Table 3: Results of Precision
|
Sample |
Area |
RT |
Theoretical Plates |
Asymmetry |
Resolu-tions |
|
Reps 1 |
3115408 |
4.767 |
17765 |
1.6658 |
5.794 |
|
Reps 2 |
3115407 |
4.773 |
17786 |
1.1582 |
5.757 |
|
Reps 3 |
3115408 |
4.773 |
17785 |
1.15046 |
5.539 |
|
Reps 4 |
3115409 |
4.773 |
17394 |
1.1211 |
5.556 |
|
Reps 5 |
3115408 |
4.773 |
17125 |
1.12252 |
5.495 |
|
Average |
3115408.12 |
4.77 |
17522.5 |
1.14 |
5.628 |
|
% RSD |
0.02 |
0.06 |
|
||
Table 4: Results of Accuracy
|
STD Wt. |
Potency |
Conc. mg/ml |
STD area |
|
5 |
99.72 |
1007.25 |
3231466 |
|
% Conc. |
Spike |
Spike amount |
Area |
Amount recovery |
% Re-covery |
Ave-rage |
% RSD |
|
80 |
0.8 |
80.6776 |
2495622 |
80.7313 |
100.13 |
100.13 |
0.02 |
|
80 |
0.8 |
80.6776 |
2495628 |
80.7313 |
100.13 |
||
|
100 |
1 |
100.487 |
3115408 |
100.487 |
100 |
100 |
0.03 |
|
100 |
1 |
100.487 |
3115408 |
100.487 |
100 |
||
|
120 |
1.2 |
120.892 |
3730868 |
119.892 |
99.80 |
99.80 |
0.07 |
|
120 |
1.2 |
120.892 |
3730869 |
119.892 |
99.80 |
Table 5: Results of LOD and LOQ
|
Parameters |
µg/ml |
|
LOD |
3.1 |
|
LOQ |
9.38 |
5. CONCLUSION:
The method developed for determination of acyclovir in ointment is rapid, precise, accurate and linear. The advantages of this method where it has short analysis time and simple procedures for preparation of sample mobile phase used in isocratic mode of elution. This method was effective and clear with low LOD and LOQ. The HPLC method for determination of acyclovir in ointment is successfully developed and validated for its expected purpose. The method was proposed as per ICH guidelines.
6. ACNOWLEDGMENT:
Authors are thankful to the D.S.T.S. Principal College of Pharmacy, Solapur for providing all the facilities for research work.
7. REFERENCES:
1. Indian Pharmacopoeia. The Indian Pharmacopoeia Commission 2007: 67-70.
2. Yadav PK, Chandanam S, Rao ST, Akkamma HG, Bharadwajan RG, Deepa MS. New analytical method development and validation of acyclovir by RP-HPLC. Unique J Pharmaceutical and Biological Sciences 2016; 4: 20-26.
3. Williams DA, Lemke TL, editors. Foye’s Principles of Medicinal Chemistry. 7th edition Philadelphia: Lippincott Williams and Wilkins, Baltimore: Wolters and Kluwer Business 2013: 1283.
4. Umesh SD, Satyam ZC, Shweta A, Jadhav and Vaibhav RP. Spectrophotometric determination and validation of acyclovir in tablet dosage form. International J Parma tech research 2012; 4(4): 1840-1845.
5. Bhagyashri PP, Sugandha VM. UV spectrophotometric estimation of acyclovir in bulk and tablet dosage form using area under curve method. World J Pharmacy and Pharmaceutical Sciences 2014; 3(8): 1644-1651.
6. Somshubhra G, Anirban SD, Satyaprabha Harani JA. Method development and validation of acyclovir in tablet form by RP-HPLC Int. J. Pharm. Sci. 2014; 4(3); 1234-1238.
7. Hayam ML et al. Stability indicating methods for the determination of acyclovir in the presence of its degradation product. Analytical Chem. an Indian J. 2010; 9(4): 398-407.
8. Ravishankar PA, Niharika S, Sireesha O, Sai K, Himaja V. Development and validation of RP-HPLC method for quantitative estimation of acyclovir in bulk drug and tablets. J Chemical and Pharmaceutical Sciences 2015; 08(01): 73-80.
9. Vilas C. and Milind UA. Validated stability indicating method HPLC assay method for acyclovir in bulk drug. International J Analytical, Pharmaceutical and Biomedical Science 2012; 23: 01-12.
10. Suchita VG, Varsha M, Jadhav and Vilasrao JK. High pressure liquid chromatographic method development and validation for estimation of acyclovir in bulk and marketed formulation. International J. of Pharmaceutical Sciences and Research 2016; 7(5): 2194-2199.
Received on 17.02.2021 Modified on 07.03.2021
Accepted on 20.03.2021 ©Asian Pharma Press All Right Reserved
Asian J. Pharm. Ana. 2021; 11(3):199-202.
DOI: 10.52711/2231-5675.2021.00035